Half Yearly Results Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 16.09% vs 14.17% in Sep 2024
Standalone Net Profit
Growth in half year ended Sep 2025 is 20.38% vs 29.52% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 17.08% vs 18.28% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 20.44% vs -20.52% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of Kovai Medical With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
764.33
267.43
496.90
185.81%
Other Operating Income
1.59
0.00
1.59
Total Operating income
765.92
267.43
498.49
186.40%
Raw Material Cost
203.43
55.77
147.66
264.77%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
147.07
51.33
95.74
186.52%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
54.78
0.00
54.78
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
147.83
98.32
49.51
50.36%
Total Expenditure (Excl Depreciation)
553.11
205.42
347.69
169.26%
Operating Profit (PBDIT) excl Other Income
212.81
62.01
150.80
243.19%
Other Income
12.08
13.41
-1.33
-9.92%
Operating Profit (PBDIT)
224.89
75.42
149.47
198.18%
Interest
17.91
0.34
17.57
5,167.65%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
206.98
75.08
131.90
175.68%
Depreciation
52.71
11.01
41.70
378.75%
Profit Before Tax
154.27
64.07
90.20
140.78%
Tax
38.19
16.30
21.89
134.29%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
116.09
47.76
68.33
143.07%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
116.09
47.76
68.33
143.07%
Equity Capital
10.94
96.35
-85.41
-88.65%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
106.12
4.96
101.16
2,039.52%
Diluted Earnings per share
109.09
4.96
104.13
2,099.40%
Operating Profit Margin (Excl OI)
27.84%
23.19%
0.00
4.65%
Gross Profit Margin
27.08%
28.07%
0.00
-0.99%
PAT Margin
15.19%
17.86%
0.00
-2.67%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 764.33 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 16.09% vs 14.17% in Sep 2024
Half Yearly - Standalone Net Profit
Standalone Net Profit 116.09 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 20.38% vs 29.52% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 212.81 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 17.08% vs 18.28% in Sep 2024
Half Yearly - Interest
Interest 17.91 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 20.44% vs -20.52% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.84%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
